詳細検索はこちら

馬場 重樹

所属部署名栄養治療部
職名講師
 
 
更新日: 18/06/20 09:40

研究者基本情報

氏名

    馬場 重樹

所属(マスタ)

  • 栄養治療部 講師

学歴

  • - 2004年滋賀医科大学 医学研究科
  • - 1998年滋賀医科大学 医学部 医学科

学位

  • 医学博士(滋賀医科大学)

経歴

  • 1998年- 2000年 滋賀医科大学附属病院消化器内科 研修医
  • 2000年- 2001年 草津総合病院消化器内科 医員
  • 2005年- 2006年 滋賀医科大学附属病院消化器内科 医員
  • 2006年- 2008年 彦根市立病院内科 医長
  • 2008年- 滋賀医科大学内科学講座消化器分野 助教

研究活動情報

研究分野

  • 内科系臨床医学 / 消化器内科学

MISC

  • Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn's disease.
    IMAEDA Hirotsugu, TAKAHASHI Kenichiro, FUJIMOTO Takehide, BAMBA Shigeki, TSUJIKAWA Tomoyuki, SASAKI Masaya, FUJIYAMA Yoshihide, ANDOH Akira
    J Gastroenterol. 49(1) 100-109 2014年
  • Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts.
    TAKAHASHI K., IMAEDA H., FUJIMOTO T., BAN H., BAMBA S., TSUJIKAWA T., SASAKI M., FUJIYAMA Y., ANDOH A.
    Clin Exp Immunol. 173(2) 323-331 2013年
  • Relationship between serum infliximab trough levels and endoscopic activities in patients with Crohn's disease under scheduled maintenance treatment.
    IMAEDA Hirotsugu, BAMBA Shigeki, TAKAHASHI Kenichiro, FUJIMOTO Takehide, BAN Hiromitsu, TSUJIKAWA Tomoyuki, SASAKI Masaya, FUJIYAMA Yoshihide, ANDOH Akira
    J Gastroenterol. 49(4) 674-682 2013年
  • Epithelial Expression of Interleukin-37b in Inflammatory Bowel Disease.
    IMAEDA H., TAKAHASHI K., FUJIMOTO T., KASUMI E., BAN H., BAMBA S., SONODA H., SHIMIZU T., FUJIYAMA Y., ANDOH A.
    Clinical & Experimental Immunology 172(3) 410-416 2013年
  • Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
    Fujimoto T., Takahashi K., Imaeda H., Bamba S., Kasumi E., Andoh A., Fujiyama Y.
    J Gastroenterol Hepatol. 28(4) 613-619 2012年
  • Prognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitors.
    Saitoh Y., Sasaki M., Fujiyama Y., Tsujikawa T., Bamba S., Imaeda H., Andoh A., Kobori A., Ban H., Shioya M., Mochizuki Y., Inatomi O., Nishimura T.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 4(1) 99-104 2012年
  • Accuracy of genotyping using the TaqMan PCR assay for single nucleotide polymorphisms responsible for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.
    ANDOH A, FUJIYAMA Y, SASAKI M, TSUJIKAWA T, BAMBA S, AOMATSU T, BAN H, IMAEDA H, OSAKI R
    Exp Ther Med. 2(5) 783-786 2011年
  • HT-29細胞におけるIL-32新規variant強制発現による炎症性サイトカインの発現様式の変化.
    消化器と免疫(47) 65-68 2011年
  • Accuracy of genotyping using the TaqMan PCR assay for single nucleotide polymorphisms responsible for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.
    ANDOH A, FUJIYAMA Y, SASAKI M, TSUJIKAWA T, BAMBA S, AOMATSU T, BAN H, IMAEDA H, OSAKI R
    Exp. Ther. Med. 2(5) 783-786 2011年
  • Interleukin-28B polymorphisms are associated with an early viral response in patients receiving hepatitis C therapy.
    ANDOH A, FUJIYAMA Y, NAKAJO S, BAMBA S, NAKAHARA T, SHIOYA M, OKUMURA Y, MAEDA H, TAKEUCHI T, NISHIMURA T, OSAKI R
    Exp Ther Med. 2(4) 715-718 2011年
  • Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis.
    IMAEDA Hirotsugu, ANDOH Akira, AOMATSU Tomoki, UCHIYAMA Kazuhiko, BAMBA Shigeki, TSUJIKAWA Tomoyuki, NAITO Yuji, FUJIYAMA Yoshihide
    Int J Mol Med 28(4) 573-578 2011年
  • A new isoform of interleukin-32 suppresses IL-8 mrna expression in the intestinal epithelial cell line ht-29.
    FUJIYAMA Y, SHIMIZU T, INATOMI O, BAMBA S, OSAKI R, AOMATSU T, ANDOH A, IMAEDA H
    Mol Med Report. 4(3) 483-487 2011年
  • The DPP-IV inhibitor ER-319711 has a proliferative effect on the colonic epithelium and a minimal effect in the amelioration of colitis.
    FUJIYAMA Y, ANDOH A, TSUJIKAWA T, SASAKI M, KOBORI A, INATOMI O, IMAEDA H, BAMBA S, BAN H
    Oncol Rep. 25(6) 1699-1703 2011年
  • Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis.
    ANDOH Akira, IMAEDA Hirotsugu, AOMATSU Tomoki, INATOMI Osamu, BAMBA Shigeki, SASAKI Masaya, SAITO Yasuharu, TSUJIKAWA Tomoyuki, FUJIYAMA Yoshihide
    J Gastroenterol. 46(4) 479-486 2011年
  • Interleukin-32α expression in human colonic subepithelial myofibroblasts.
    YAGI Yuhki, ANDOH Akira, IMAEDA Hirotsugu, AOMATSU Tomoki, OHSAKI Rie, INATOMI Osamu, BAMBA Shigeki, TSUJIKAWA Tomoyuki, SHIMIZU Tomoharu, FUJIYAMA Yoshihide
    Int J Mol Med. 27(2) 263-268 2011年
  • Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines.
    Ayako Kobori, Shigeki Bamba, Hirotsugu Imaeda, Hiromitsu Ban, Tomoyuki Tsujikawa, Yasuharu Saito, Yoshihide Fujiyama, Akira Andoh
    World J Gastroenterol.  16(19) 2355-2361 2010年
  • Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis.
    KOBORI Ayako, YAGI Yuhki, IMAEDA Hirotsugu, BAN Hiromitsu, BAMBA Shigeki, TSUJIKAWA Tomoyuki, SAITO Yasuharu, FUJIYAMA Yoshihide, ANDOH Akira
    J Gastroenterol. 45(10) 999-1007 2010年
  • The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.
    BAN Hiromistu, ANDOH Akira, IMAEDA Hirotsugu, KOBORI Ayako, BAMBA Shigeki, TSUJIKAWA Tomoyuki, SASAKI Masaya, SAITO Yasuharu, FUJIYAMA Yoshihide
    J Gastroenterol. 45(10):1014-21 45(10) 1014-1021 2010年
  • Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease.
    ANDOH Akira, SHIOYA Makoto, NISHIDA Atsushi, BAMBA Shigeki, TSUJIKAWA Tomoyuki, KIM‐MITSUYAMA Shokei, FUJIYAMA Yoshihide
    J Immunol.  183(1) 687-695 2009年
  • Alendronate improves low bone mineral density induced by steroid therapy in Crohn's disease.
    TSUJIKAWA Tomoyuki, TSUJIKAWA Tomoyuki, TSUJIKAWA Tomoyuki, ANDOH Akira, ANDOH Akira, ANDOH Akira, INATOMI Osamu, INATOMI Osamu, INATOMI Osamu, BAMBA Shigeki, BAMBA Shigeki, BAMBA Shigeki, NAKAHARA Tamio, NAKAHARA Tamio, NAKAHARA Tamio, SASAKI Masaya, SASAKI Masaya, SASAKI Masaya, SAITO Haruyasu, SAITO Haruyasu, SAITO Haruyasu, FUJIYAMA Yoshihide, FUJIYAMA Yoshihide, FUJIYAMA Yoshihide
    Intern Med 48(12) 933-937 2009年
  • Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
    ANDOH A, TSUJIKAWA T, BAN H, HASHIMOTO T, BAMBA S, OGAWA A, SASAKI M, SAITO Y, FUJIYAMA Y
    J Gastroenterol Hepatol. 23(9) 1373-1377 2008年
  • Microarray Analysis of Leukocytapheresis-induced Changes in Gene Expression Patterns of Peripheral Blood Mononuclear Cells in Patients With Ulcerative Colitis.
    YAGI Yuhki, ANDOH Akira, OGAWA Atsuhiro, BAMBA Shigeki, TSUJIKAWA Tomoyuki, SASAKI Masaya, MITSUYAMA Keiichi, FUJIYAMA Yoshihide
    Ther Apher Dial 11(5) 331-336 2007年
  • Curcumin Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis.
    DEGUCHI Y, ANDOH A, INATOMI O, YAGI Y, BAMBA S, ARAKI Y, HATA K, TSUJIKAWA T, FUJIYAMA Y
    Digest Dis Sci 2007 Nov;52(11):2993-8 52(11) 2993-2998 2007年
  • Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut ?
    ANDOH A, BAMBA S, BRITTAN M, FUJIYAMA Y, WRIGHT Na
    Pharmacol Therapeut  114(1) 94-106 2007年
  • Interaction between interleukin-17-producing CD4(+) T cells and colonic subepithelial myofibroblasts: what are they doing in mucosal inflammation?
    ANDOH Akira, OGAWA Atsuhiro, BAMBA Shigeki, FUJIYAMA Yoshihide
    J Gastroenterol.  42(Supplement 17) 29-33 2007年
  • Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
    J Pathol.  209(2) 265-273 2006年
  • The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
    Oncol Rep 16(4) 699-703 2006年
  • Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis.
    YAGI Yuhki, ANDOH Akira, INATOMI Osamu, BAMBA Shigeki, TSUJIKAWA Tomoyuki, FUJIYAMA Yoshihide, MITSUYAMA Keiichi, YOSHIDA Takashi
    J Gastroenterol. 41(6) 540-546 2006年
  • Regulation of amphiregulin and epiregulin expression in human colonic subepithelial myofibroblasts.
    Int J Mol Med 18(3) 497-503 2006年
  • Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.
    Oncol Rep 168(1) 103-107 2006年
  • Increased aggregation response of platelets in patients with inflammatory bowel disease.
    ANDOH Akira, YOSHIDA Takashi, YAGI Yuki, BAMBA Shigeki, HATA Kazunori, TSUJIKAWA Tomoyuki, KITOH Katsuyuki, SASAKI Masaya, FUJIYAMA Yoshihide
    J Gastroenterol. 41(1) 47-54 2006年
  • Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response.
    ANDOH Akira, BAMBA Shigeki, FUJIYAMA Yoshihide, BRITTAN Mairi, WRIGHT Nicholas A.
    J. Gastroenterol 40(12) 1089-1099 2005年
  • Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line
    ARAKI Y, KATOH T, OGAWA A, BAMBA S, ANDOH A, KOYAMA S, FUJIYAMA Y, BAMBA T
    Free Radical Biology & Medicine 39(6) 769-780 2005年
  • Interleukin-17 and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts
    ZHANG Zb, ANDOH A, INATOMI O, BAMBA S, TAKAYANAGI A, SHIMIZU N, FUJIYAMA Y
    Journal of Gastroenterology and Hepatology 20(4) 619-627 2005年
  • Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts.
    ANDOH A, BAMBA S, FUJINO S, INATOMI O, ZHANG Zb, KIM S, TAKAYANAGI A, SHIMIZU N, FUJIYAMA Y
    Pancreas. 29(4) 278-283 2004年
  • Role of Fibroblast Growth Factor-2 in the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in
    YASUI H, ANDOH A, BAMBA S, INATOMI O, ISHIDA H, FUJIYAMA Y
    Digestion 69(1) 34-44 2004年
  • Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17.
    J Gastroenterol. 38(6) 548-554 2003年
  • Increased expression of interleukin 17 in inflammatory bowel disease
    GUT 52(1) 65-70 2003年
  • Regulation of IL-11expression in intestinal myofibroblasts: role of c-Jun AP-1 and MAPK-dependent pathways
    Am J Physiol Gastrointest Liver Physiol 285 G529-G538 2003年
  • IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts.
    Am J Physiol Gastrointest Liver Physiol. 282(6) G1035-G1044 2002年
  • Inhibitory effectsInhibitory effects of somatostatin on tumor necrosis factor-alpha-induced interleukin-6 secretion in human pancreatic periacinar myofibroblasts.
    Int J Mol Med. 10(1) 89-93 2002年
  • Dietary bile acids inhibit potentially elemental diet-induced small intestinal atrophy in rats.
    Int J Mol Med. 10(5) 623-626 2002年
  • IL-17 Selectively Down-Regulates TNF-alpha-Induced RANTES Gene Expression in Human Colonic Subepithelial Myofibroblasts.
    J Immunol. 169(4) 1683-1687 2002年
  • Extracellular signal-regulated kinases 1 and 2 participate in interleukin-17plus tumor necrosis factor-?
    Biochimica et Biophysica Acta 59 69-74 2002年
  • Interleukin-1beta and tumor necrosis factor-alfa induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts
    Scand J Gastroenterol 37 317-324 2002年
  • Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells.
    ANDOH A, TAKAYA H, MAKINO J, SATO H, BAMBA S, ARAKI Y, HATA K, SHIMADA M, OKUNO T, FUJIYAMA Y, BAMBA T
    Clin Exp Immunol. 125(1) 56-63 2001年
  • Interleukin-17 stimulates chemokine (interleukin-8 and monocyte chemoattractant protein-1) secretion in human pancreatic periacinar myofibroblasts.
    TAKAYA H, ANDOH A, MAKINO J, SHIMADA M, TASAKI K, ARAKI Y, BAMBA S, HATA K, FUJIYAMA Y, BAMBA T
    Scand J Gastroenterol.  37(2) 239-245 2001年

競争的資金

  • Toll様受容体(TLR-9)を標的とした新たな炎症性腸疾患治療開発の基礎検討
  • Toll様受容体(TLR-9)を標的とした新たな炎症性腸疾患治療開発の基礎検討